Price
$0.35
Decreased by -14.84%
Dollar volume (20D)
2.49 M
ADR%
14.63
Shares float
7.45 M
Shares short
7.83 K [0.11%]
Shares outstanding
9.38 M
Market cap
10.16 M
Beta
N/A
Price/earnings
N/A
20D range
0.25 0.49
50D range
0.25 0.65
200D range
0.25 1.09

iTonic Holdings Ltd., a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy.

Its proprietary treatment planning system is a radioactive particle implantation, a radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors.

The company offers FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients.

The company was formerly known as Pheton Holdings Ltd and changed its name to iTonic Holdings Ltd. in January 2026. iTonic Holdings Ltd. was founded in 1998 and is headquartered in Beijing, China. iTonic Holdings Ltd. operates as a subsidiary of ZJW (BVI) LTD.

Reported date EPSChange YoY EstimateSurprise
Dec 16, 25 -0.14 -
Mar 20, 25 -0.03 -
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Jun 30, 25 67.51 K
Decreased by -74.70%
-2.04 M
Decreased by -2.34 K%
Decreased by -3.02 K%
Decreased by -9.53 K%
Dec 31, 24 237.71 K
Decreased by -18.74%
-375.46 K
Decreased by -3.13 K%
Decreased by -157.95%
Decreased by -3.83 K%
Jun 30, 24 210.49 K
Decreased by -45.65%
-285.13 K
Decreased by -498.28%
Decreased by -135.46%
Decreased by -832.77%
Dec 31, 23 361.80 K - -157.62 K -
Decreased by -43.56%
-
Jun 30, 23 266.79 K - -83.60 K -
Decreased by -31.34%
-
Dec 31, 22 292.52 K - 12.39 K -
Increased by +4.24%
-
Jun 30, 22 387.26 K - 71.59 K -
Increased by +18.49%
-
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY